Easypharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -63.56%
- Profit Growth 50.42%
- Ebitda 50.77%
- Net Worth -18.91%
- Total Assets -21.33%
About Easypharma Solutions
Easypharma Solutions Private Limited (ESPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 April 2009 and has a history of 15 years and nine months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Shri Parshvanath Investment Consultancy Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Pillai and Aniket Bora serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51900PN2009PTC133834
-
Company No.
133834
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Apr 2009
-
Date of AGM
30 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Easypharma Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aniket Bora
|
Director | 01-Apr-2011 | Current |
|
Prashant Pillai
|
Director | 25-Jan-2017 | Current |
Financial Performance of Easypharma Solutions.
Easypharma Solutions Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 63.56% decrease. The company also saw a substantial improvement in profitability, with a 50.42% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Easypharma Solutions?
In 2020, Easypharma Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medsonway Solutions Private LimitedPrashant Pillai and Aniket Bora are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Easypharma Solutions?
Easypharma Solutions has a workforce of 3 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Easypharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Easypharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
